These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33801447)

  • 1. Dose-Dependent Solubility-Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions.
    Sugita K; Takata N; Yonemochi E
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33801447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation.
    Miller JM; Beig A; Krieg BJ; Carr RA; Borchardt TB; Amidon GE; Amidon GL; Dahan A
    Mol Pharm; 2011 Oct; 8(5):1848-56. PubMed ID: 21800883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Effective Improvement of Absorption for Some Nanoparticle Formulations Explained by Permeability under Non-Sink Conditions.
    Sugita K; Takata N; Yonemochi E
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicity.
    Katneni K; Charman SA; Porter CJ
    J Pharm Pharmacol; 2008 Oct; 60(10):1311-9. PubMed ID: 18812024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs.
    Kataoka M; Masaoka Y; Yamazaki Y; Sakane T; Sezaki H; Yamashita S
    Pharm Res; 2003 Oct; 20(10):1674-80. PubMed ID: 14620525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Role of Sodium Lauryl Sulfate on the Biorelevant Solubility of a Combination of Poorly Water-Soluble Drugs Using High Throughput Experimentation and Mechanistic Absorption Modeling.
    Bahr MN; Modi D; Patel S; Campbell G; Stockdale G
    J Pharm Pharm Sci; 2019; 22(1):221-246. PubMed ID: 31219781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs.
    Stewart AM; Grass ME
    Mol Pharm; 2020 Jan; 17(1):180-189. PubMed ID: 31743032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing a Novel Coamorphous Salt Formulation of Telmisartan with Amlodipine to Enhance Permeability and Oral Absorption.
    Hatanaka Y; Uchiyama H; Kaneko S; Ueda K; Higashi K; Moribe K; Furukawa S; Takase M; Yamanaka S; Kadota K; Tozuka Y
    Mol Pharm; 2023 Aug; 20(8):4071-4085. PubMed ID: 37498232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the unstirred water layer on permeability enhancement by hydrophilic cyclodextrins.
    Brewster ME; Noppe M; Peeters J; Loftsson T
    Int J Pharm; 2007 Sep; 342(1-2):250-3. PubMed ID: 17560057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.
    Fine-Shamir N; Beig A; Zur M; Lindley D; Miller JM; Dahan A
    Mol Pharm; 2017 Jun; 14(6):2138-2146. PubMed ID: 28505451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.
    Ruponen M; Visti M; Ojarinta R; Laitinen R
    Eur J Pharm Biopharm; 2018 Aug; 129():247-256. PubMed ID: 29894814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity.
    Tang L; Khan SU; Muhammad NA
    Pharm Dev Technol; 2001 Nov; 6(4):531-40. PubMed ID: 11775954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of absorption potential of poorly water-soluble drugs by using the dissolution/permeation system.
    Kataoka M; Yano K; Hamatsu Y; Masaoka Y; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1317-24. PubMed ID: 23811221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug permeation through biomembranes: cyclodextrins and the unstirred water layer.
    Loftsson T
    Pharmazie; 2012 May; 67(5):363-70. PubMed ID: 22764564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations.
    Miller JM; Beig A; Carr RA; Webster GK; Dahan A
    Mol Pharm; 2012 Mar; 9(3):581-90. PubMed ID: 22280478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Non-linear Pharmacokinetics of P-Glycoprotein Substrates in a Microfluidic Device Using a Mathematical Model that Includes an Unstirred Water Layer (UWL) Compartment.
    Igarashi F; Nakagawa T; Shinohara Y; Tachibana T
    Pharm Res; 2021 Jun; 38(6):1031-1039. PubMed ID: 34009624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Solubility Improvement via Formation of an Amorphous Composite of Indomethacin and Sulindac on Membrane Permeability.
    Hatanaka Y; Uchiyama H; Furukawa S; Takase M; Yamanaka S; Kadota K; Tozuka Y
    Chem Pharm Bull (Tokyo); 2023; 71(3):257-261. PubMed ID: 36858532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.